ClariVest Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$994K Hold
64,027
0.1% 263
2024
Q2
$994K Buy
64,027
+1,810
+3% +$21.9K 0.1% 263
2024
Q1
$659K Buy
62,217
+117
+0.2% +$1.17K 0.07% 338
2023
Q4
$745K Buy
+62,100
New +$509K 0.04% 311
2022
Q2
Sell
-8,619
Closed -$319K 693
2022
Q1
$319K Hold
8,619
0.01% 435
2021
Q4
$393K Sell
8,619
-515
-6% -$26.9K 0.01% 450
2021
Q3
$579K Sell
9,134
-343
-4% -$26.1K 0.02% 421
2021
Q2
$868K Buy
9,477
+22
+0.2% +$1.75K 0.03% 317
2021
Q1
$643K Buy
9,455
+1,452
+18% +$113K 0.02% 370
2020
Q4
$580K Buy
+8,003
New +$464K 0.02% 351
2019
Q4
Sell
-65,754
Closed -$1.49M 655
2019
Q3
$1.49M Buy
65,754
+23,353
+55% +$647K 0.03% 295
2019
Q2
$1.53M Buy
+42,401
New +$1.36M 0.03% 277

Other funds holding CDNA

ClariVest Asset Management's CDNA Position: Q3 2024 in Review

ClariVest Asset Management held its CareDx (CDNA) position steady in Q3 2024 at 64,027 shares worth $994K. The position accounts for 0.1% of the portfolio, ranked #263.

ClariVest Asset Management first reported a position in CDNA in Q2 2019 and has held it in 12 quarters since. The position peaked at $1.53M in Q2 2019. 215 funds tracked by Wall St. Rank hold CDNA as of Q3 2024.

  • ClariVest Asset Management held 64,027 shares of CareDx worth $994K as of Q3 2024.
  • ClariVest Asset Management left its CareDx share count unchanged in Q3 2024.
  • CareDx made up 0.1% of ClariVest Asset Management's portfolio in Q3 2024, its #263 holding.
  • ClariVest Asset Management first reported a position in CareDx in Q2 2019 and has held it in 12 quarters since.
  • ClariVest Asset Management's CareDx position peaked at $1.53M in Q2 2019.
  • 215 funds tracked by Wall St. Rank held CareDx as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.